Digoxin recalled over mislabeling Two lots of Digoxin were mislabeled, leading to a recall. Digoxin is used for the treatment of mild to moderate heart failure in children and adults. The Food and ...

Arrow International is recommending dialysis catheter kits containing Merit Medical 16F Dual-Valved Splittable Sheath Introducers be taken out of use due to a design defect where the sheath introducer ...

Section 271(b) defines liability for inducing the direct infringement of another party: "whoever actively induces infringement of a patent shall be liable as an infringer." The case involved GSK's ...

The Food and Drug Administration has announced a recall of Infla-650 Herbal Dietary Supplement Capsules which were marketed for pain relief. The capsules were tainted with acetaminophen, diclofenac ...

Senators introduced legislation on Thursday that would require prescription drug labels to identify where the medication was made, adding momentum to a yearslong campaign to bring more transparency to ...

If an optional autoinjector is used for administration, patients should ensure the device is compatible for use with their specific glatiramer acetate product. The labels for glatiramer acetate ...

The FDA is looking at a slew of label expansions this month, including one that could open up home-based treatments for Alzheimer’s disease.

The Food and Drug Administration announced the recall of one lot of Digoxin Tablets USP, 0.125 mg, and one lot of Digoxin Tablets USP, 0.25 mg. Bottles of Digoxin Tablets, USP 0.125 mg are incorrectly ...